GlassScriptPhysician profile
Melanie Oliver
NPI 1528389723
$5,545.07
in general payments reported to CMS, 2019-2025
48 companies · $1,141 in 2025
The $1,141 reported for 2025 was more than what 87% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,055 · 2022: $974 · 2023: $1,191 · 2024: $1,184 · 2025: $1,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,515.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $539.77 | 2021-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $500.27 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $448.38 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $414.12 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $368.56 | 2021-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $324.37 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Sanofi-Aventis U.S. LLC | $259.06 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $239.61 | 2021-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $233.19 | 2022-2025 | Rexulti |
| Novo Nordisk INC | $218.04 | 2021-2025 | Wegovy |
| Pfizer INC. | $161.74 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $144.43 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $142.23 | 2023-2025 | |
| Amarin Pharma, INC. | $141.93 | 2021 | |
| Merck Sharp & Dohme LLC | $135.91 | 2022-2025 | Capvaxive, Gardasil 9, Gardasil |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.